Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950138-07-000156
Filing Date
2007-02-14
Accepted
2007-02-14 14:11:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 feb13ga-poniard.htm SC 13G/A 61351
  Complete submission text file 0000950138-07-000156.txt   63182
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40119 | Film No.: 07618091
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G/A